According to new results of the Colorectal Adenoma/Carcinoma Prevention Program 3 (CaPP3) study presented at the International Cancer Prevention Conference in London, low-dose aspirin (100 mg) lowered the risk of colorectal cancer in patients with Lynch syndrome. Additionally, the use of aspirin lowered the risk of all cancers associated with Lynch syndrome.
Learn more by reading the full article at: https://www.medpagetoday.com/meetingcoverage/additionalmeetings/116301
Reference: Charles Bankhead. Low-Dose Aspirin Reduces Colon Cancer Risk in Patients With Lynch Syndrome. MedPage Today. Published January 27, 2025.
